Page 133 - 2023-06-中国全科医学
P. 133
·774· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn February 2023, Vol.26 No.6
Eur J Vasc Endovasc Surg,2011,41(4):554-565. DOI: of the literature with case reports[J]. Circulation,1950,1(2):
10.1016/j.ejvs.2011.01.010. 225-240. DOI:10.1161/01.cir.1.2.225.
[10]BEHRAVESH S,HOANG P,NANDA A,et al. Pathogenesis of [23]GRIM HOSTETLER S,SOPKOVICH J,DEAN S,et al.
thromboembolism and endovascular management[J]. Thrombosis, Warfarin-induced venous limb gangrene[J]. J Clin Aesthet
2017,2017:3039713. DOI:10.1155/2017/3039713. Dermatol,2012,5(11):38-42.
[11]STANLEY G A,MURPHY E H,PLUMMER M M,et al. Midterm [24]WARKENTIN T E. Heparin-induced thrombocytopenia-associated
results of percutaneous endovascular treatment for acute and chronic thrombosis:from arterial to venous to venous limb gangrene[J].
deep venous thrombosis[J]. J Vasc Surg Venous Lymphat J Thromb Haemost,2018,16(11):2128-2132. DOI:
Disord,2013,1(1):52-58. DOI:10.1016/j.jvsv.2012.04.002. 10.1111/jth.14264.
[12]赵辉,胡红耀,饶珉,等 . 经皮机械性血栓清除术治疗急性髂 [25]WARKENTIN T E,GREINACHER A,KOSTER A,et al.
股静脉血栓[J]. 中国介入影像与治疗学,2020,17(7): Treatment and prevention of heparin-induced thrombocytopenia:
393-397. DOI:10.13929/j.issn.1672-8475.2020.07.003. American college of chest physicians evidence-based clinical
[13]PÁRAMO J A,LOZANO M L,GONZÁLEZ-PORRAS J R,et al. practice guidelines(8th edition)[J]. Chest,2008,133(6
Current status of diagnosis and treatment of heparin-induced Suppl):340S-380S. DOI:10.1378/chest.08-0677.
thrombocytopenia (HIT)[J]. Med Clin(Barc),2022,158(2): [26]TAN J H,MOHAMAD Y,TAN C L H,et al. Concurrence of
82-89. DOI:10.1016/j.medcli.2021.05.020. symmetrical peripheral gangrene and venous limb gangrene following
[14]WARKENTIN T E,ROBERTS R S,HIRSH J,et al. An improved polytrauma:a case report[J]. J Med Case Rep,2018,12(1):
definition of immune heparin-induced thrombocytopenia in 131. DOI:10.1186/s13256-018-1684-1.
postoperative orthopedic patients[J]. Arch Intern Med,2003,
[27]LAOHAPENSANG K,HANPIPAT S,AWORN S,et al. Surgical
163(20):2518-2524. DOI:10.1001/archinte.163.20.2518.
venous thrombectomy for phlegmasia cerulea dolens and venous
[15]MARTEL N,LEE J,WELLS P S. Risk for heparin-induced
gangrene of the lower extremities[J]. J Med Assoc Thai,2013,
thrombocytopenia with unfractionated and low-molecular-weight
96(11):1463-1469.
heparin thromboprophylaxis:a meta-analysis[J]. Blood,2005,
[28]张玥 . 深静脉血栓形成“瘀热互结”病机浅析[J]. 中医
106(8):2710-2715. DOI:10.1182/blood-2005-04-1546.
杂 志,2009,50(11):1049-1050. DOI:10.13288/j.11-
[16]LINKINS L A,BATES S M,LEE A Y Y,et al. Combination
2166/r.2009.11.031.
of 4Ts score and PF4/H-PaGIA for diagnosis and management
[29]王冰,关徐涛,王涛,等 . 免疫性血小板减少症治疗体会[J].
of heparin-induced thrombocytopenia:prospective cohort
中医杂志,2016,57(18):1608-1610. DOI:10.13288/j.11-
study[J]. Blood,2015,126(5):597-603. DOI:
2166/r.2016.18.018.
10.1182/blood-2014-12-618165.
[30]贾恒,李肆柱,张溪,等 . 扶正益气生血方治疗结直肠肿瘤
[17]CUKER A,AREPALLY G M,CHONG B H,et al. American
化疗所致血小板减少症的临床效果[J]. 临床医学研究与实
Society of Hematology 2018 guidelines for management of venous
践,2020,5(36):142-144. DOI:10.19347/j.cnki.2096-
thromboembolism:heparin-induced thrombocytopenia[J]. Blood
1413.202036054.
Adv,2022,2(22):3360-3392. DOI:10.1182/bloodadvanc
[31]赵敏,任德祥,夏小军 . 中医药治疗原发免疫性血小板减少
es.2018024489.
症 1 例[J]. 甘肃医药,2021,40(11):1051-1052. DOI:
[18]NG H J,THAN H,TEO E C Y. First experiences with
10.15975/j.cnki.gsyy.2021.11.036.
the use of rivaroxaban in the treatment of heparin-induced
[32]张晶,罗昌国,王济国,等 . 升板汤治疗化疗所致血小板减少
thrombocytopenia[J]. Thromb Res,2015,135(1):205-
症的临床研究[J]. 辽宁中医杂志,2021,48(12):133-
207. DOI:10.1016/j.thromres.2014.06.005.
136. DOI:10.13192/j.issn.1000-1719.2021.12.038.
[19]LINKINS L A,WARKENTIN T E. Rivaroxaban for treatment of
[33]宋玮,艾儒棣,肖敏,等 . 中医外科名家艾儒棣运用“通法”
HIT:a riveting first experience[J]. Thromb Res,2015,135(1):
辨治脱疽经验[J]. 时珍国医国药,2021,32(10):2519-
1-2. DOI:10.1016/j.thromres.2014.10.019.
2521.
[20]HANTSON P,LAMBERT C,HERMANS C. Rivaroxaban
[34]MOU Y,WANG X Z,WANG T,et al. Clinical application and
for arterial thrombosis related to heparin-induced
pharmacological mechanism of Wuling Powder in the treatment
thrombocytopenia[J]. Blood Coagul Fibrinolysis,2015,26(2):
of ascites:a systematic review and network pharmacological
205-206. DOI:10.1097/MBC.0000000000000205.
analysis[J]. Biomedecine Pharmacother,2022,146:112506.
[21]蒋京军,张小明,李伟,等 . 利伐沙班治疗肝素诱导的血小板
DOI:10.1016/j.biopha.2021.112506.
减少症[J]. 中华普通外科杂志(电子版),2017,32(2):
(收稿日期:2022-06-08;修回日期:2022-08-06)
160-163. DOI:10.3760/cma.j.issn.1007-631X.2017.02.019.
(本文编辑:宋春梅)
[22]HAIMOVICI H. Gangrene of the extremities of venous origin;review